Experts discuss how knowledge of lipoprotein(a) (Lp[a]) levels can empower patients in managing atherosclerotic ...

CRISPR Therapeutics’ partner Vertex reported that more than 65 treatment centers have been activated for the gene therapy ...

This stealthy threat, called lipoprotein(a) or Lp(a), has long evaded both detection and treatment—until now. A groundbreaking experimental medication called lepodisiran is showing extraordinary ...

A recent study published in the European Heart Journal investigated lipoproteins containing apolipoprotein B, a protein ...

Lipoprotein apheresis involves the extracorporeal ... Compared with baseline value off all lipid-lowering treatment. –: No baseline values were specified in the guidelines for these patient ...

High levels of a lipoprotein that is believed to be behind sudden and inexplicable heart attacks and strokes could soon have multiple drugs to treat it Why seemingly healthy Indians in their ...

Lp(a) is a form of lipoprotein capable of carrying cholesterol ... These results offer hope for a long-term, durable treatment option. “This data underscores Lilly's commitment to advancing ...

Until now. Last week, Eli Lilly and Company announced results of a Phase 2 trial that demonstrated its drug, Lepodisiran, significantly reduced “the production of lipoprotein(a) levels by an average ...

A new study led by Nudy suggests that extended use of estrogen-based hormone therapies could offer benefits for cardiov ...

A recent study suggests that measuring levels of apolipoprotein B particles and lipoprotein(a) could help predict the risk of coronary artery disease. These findings could contribute to a shift in ...